Cetylpyridinium chloride

ApprovedSmall molecule

Sanofi

Cetylpyridinium chloride is one of 42 small molecule programs targeting Gingivitis. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

GingivitisActive, not recruiting

SarcopeniaActive, not recruiting

GingivitisApproved

Active, not recruiting

SarcopeniaPhase 1

Active, not recruiting

Competition

Competitive Landscape

45 competitors in Gingivitis

#DrugCompanyPhaseTrials

Flagyl

DDePuy Orthopaedics

Approved

3 2

Peridex

DDexcel Pharma Technologies Ltd.

Approved

2 3

Cetylpyridinium chloride

Sanofi

Approved

1 4

Tea Tree Oil

FFederal University of São Paulo

Approved

1 5

Triclosan

CColgate Palmolive

Phase 3

1 6

Active Comparator

Moderna

Phase 2

1 7

Negative Control

GSK

Phase 3

1 8

Test

RRespirent Pharmaceuticals Co Ltd.

Phase 2

2 9

Sodium Laural Sulfate

GSK

Phase 3

1 10

Deltavit

HHyundai Pharmaceutical Co., LTD.

Phase 1

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Sarcopenia2 trials

Preventive Effects of Cetylpyridinium Chloride on SarcopeniaStudy

Completed·SSeoul National University Hospital·Phase 1·NCT02297997·65 enrolled

Clinical Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia

Completed·SSeoul National University Hospital·Phase 1·NCT02575235·100 enrolled

Acceptability2 trials

Safety Dermatological Evaluation: Acceptability With Odontological Follow up - Cepacol Teen.

Completed· Sanofi logo

Sanofi·Phase 3·NCT00729599·31 enrolled

Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela Power

Completed· Sanofi logo

Sanofi·Phase 3·NCT00687037·30 enrolled

Pregnant Women1 trial

Feasibility and Acceptability of Use of Daily Oral Rinse in Pregnant Women in Rural Nepal

Completed·JJohns Hopkins Bloomberg School of Public Health·Phase 2·NCT02788786·175 enrolled

Efficacy1 trial

Clinical Efficacy of the Combined Effect of Oral Irrigator and Chemicals (0.075% CPC)

Completed·CColgate Palmolive·Phase 3·NCT06607172·30 enrolled

Concentration1 trial

Salivary Drug Concentration Exploratory Study of Cetylpyridinium Chloride Buccal Tablets

Completed·PPeking University People's Hospital·Phase 4·NCT05802628·10 enrolled

1 more indication

Gingivitis1 trial

A Study is to Evaluate a Regimen on Gingivitis Using Traditional and Novel Assessment Methods

Completed·PProcter and Gamble·Phase 4·NCT07211061·69 enrolled

Sources

References

[1]
ClinicalTrials.gov — 8 trial records for Cetylpyridinium chloride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Cetylpyridinium chloride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Cetylpyridinium chloride. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sanofi company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: Sanofi

Cetylpyridinium chloride

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Sarcopenia2 trials

Acceptability2 trials

Pregnant Women1 trial

Efficacy1 trial

Concentration1 trial

Gingivitis1 trial

References

Drug Info

Quick Facts

Related News